Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical Center (Radboudumc) in Nijmegen, the Netherlands will increase their SMRT sequencing capacity with the addition of two new PacBio Sequel IIe Systems. Radboudumc has been using PacBio long-read technology... Read more